Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.04
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.04, versus $0.09 reported last year. Revenue for the quarter came in at $7.4 million, versus $8.9 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
